SCCF Sachem Q4 2025 earnings vastly beat analyst expectations with shares remaining flat in regular session trading What is affecting Myriad Genetics MYGN stock valuation Q4 2025 EPS Beats Forecasts Amgen Inc AMGN Sustained Biotech Sector Outperformance Backed by MoatLike Competitive Advantages HIG The reports 10 Q1 2026 EPS miss stock falls 37 on weak investor reaction SP Global SPGI Q1 2026 Earnings Preview Key Metrics Peer Benchmarks and Market Expectations Agnico Eagle Mines Limited AEM Consecutive Insider SellOffs Signal Potential NearTerm Valuation Weakness